Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bazedoxifene and Cholecalciferol DDI Study
NCT03234244Phase 1Completed
- Sponsor
- Hyundai Pharmaceutical Co., Ltd.
- Start
- Apr 2017
- Primary completion
- Aug 2017
- Modality
- Orthosteric Ligands, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial in osteoporosis comparing Bazedoxifene 20mg, Cholecalciferol and Bazedoxifene 20mg and Cholecalciferol (3 arms). Primary endpoint: Drug-Drug Interaction. Started Apr 2017; status: completed.
02
Drugs
bazedoxifenevitamin d
03
Conditions
osteoporosis
Beyond the preview
Go deeper on NCT03234244.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03234244.